June 22, 2026 · Journal of hepatology · DOI: 10.1016/j.jhep.2026.06.021

The Hepato-Exposome Axis: How Endocrine Disruptors Hijack Liver Receptors to Drive MASLD

Listen to this summary

This review investigates how endocrine-disrupting chemicals (EDCs) contribute to the rising incidence of metabolically dysfunction-associated steatotic liver disease (MASLD) beyond traditional factors like obesity and diet. The authors propose the "hepato-exposome axis" framework to elucidate the interactions between specific EDCs and hepatic nuclear receptors, highlighting their roles in lipid metabolism, glucose homeostasis, and inflammation. They emphasize the need for further research on EDC mixtures and their effects on vulnerable populations to better understand and address the global MASLD burden.

M Martín-Grau, J H Kamstra, T Hyötyläinen, M Orešič, Y Song, N Veličković, A Djordjevic, D Vojnović Milutinović, R F Jackson, R van Vorstenbosch, J Massart, A Vidal-Puig, S Carobbio

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play